Grip Molecular Technologies announced it raised $500,000 in an initial filing from an offering of $500,000

Company

Location

About

GRIP Molecular’s novel technology increase the accuracy of existing rapid medical diagnostic technologies, enabling them to provide lab-quality diagnostic results, in minutes. GRIP's approach is low cost and can be readily applied to expand both the use frequency and use applications of existing diagnostic technologies. It leverages existing production infrastructure and established regulatory pathways to expedite development, production scale-up and commercialization. GRIP's technology will have a positive impact on clinical workflows, medical costs, patient satisfaction and clinical outcomes.